Does HRT Cause Weight Gain? What The Evidence Says

Article Summary

• During perimenopause and menopause itself, physiological, hormonal and metabolic changes mean that weight gain may be a concern.
• Hormone Replacement Therapy (HRT) manages menopausal symptoms and its influence extends to metabolic health and body composition.
• A healthy lifestyle including a nutritious diet and exercise, stress management and sleep are key. GLP-1s may also play a role in weight management.

HRT and menopause weight gain

The metabolic shifts and body composition changes associated with menopause can make managing your weight feel more challenging, despite consistent efforts with diet and exercise.

Understanding the underlying science and exploring treatment options helps you navigate this phase with confidence and wellbeing. Menopause can be a time of self-discovery and empowerment, with the right tools to make the choices that best support you.

This article explains why weight gain can happen during menopause, how Hormone Replacement Therapy (HRT) and GLP-1 medications work, and how using them together can help support metabolic health.

What is HRT? Understanding oestrogen and progesterone therapy

HRT involves administering hormones, typically oestrogen, to make up for the body's declining natural production.

In women who still have a uterus, progesterone is usually given with oestrogen to protect the uterine lining.

HRT can be administered in various forms, including pills, patches, gels, sprays, or vaginal inserts, allowing for personalised treatment plans. Its main purpose is to reduce menopausal symptoms such as hot flushes, night sweats, vaginal dryness, and mood swings.

Menopause and HRT prescriptions

The menopausal transition is marked by declining oestrogen and progesterone levels, leading to a host of physical and emotional changes. [1]

One of the most common changes is weight gain, especially around the abdomen. Changes in body shape are also frequently noted. For many people, weight-loss methods that used to work, including diet and exercise changes, stop working during menopause.

HRT prescriptions have seen a notable rise, increasing 72 percent from Q2 2021 to Q3 2025 among women aged 50 to 65, indicating a greater awareness and acceptance of these treatments for menopausal symptom management. [2]

In 2023/24, the NHS prescribed around 13 million HRT items. This was a 22% increase from the year before, showing how widely HRT is now used. [3]

Menopause and weight gain

The menopause transition, including perimenopause and menopause itself, involves hormonal changes that directly affect body composition and metabolism.

As oestrogen production declines, the body's fat distribution patterns changes. Lower oestrogen can also influence insulin sensitivity, making it harder for the body to use glucose effectively, which can lead to further weight gain and an increased risk for diabetes.

HRT, GLP-1s, and the scientific intersection

The convergence of research into HRT and GLP-1 medications, such as Mounjaro and Wegovy, present new ways to approach weight management during and after menopause.

While HRT has long been recognised for its efficacy in managing menopausal symptoms like hot flushes, its influence extends to metabolic health and body composition.

Understanding how these two distinct therapeutic approaches interact, and the scientific basis for their combined potential, can help unlock more effective ways for women facing midlife weight gain.

Changes in your metabolic rate

Following menopause, women often experience a decrease in their Basal Metabolic Rate (BMR), the number of calories the body burns at rest. This slowdown means that the same caloric intake that was once sufficient for maintaining weight can now lead to a surplus, resulting in weight gain. [4]

Results suggest that the menopausal transition is accompanied with a decline in energy expenditure, mainly characterised by a decrease in physical activity and a shift to a more sedentary lifestyle.

Contributing to this metabolic slowdown is the age-related loss of muscle mass. Muscle tissue is more metabolically active than fat tissue, meaning it burns calories even at rest. As muscle mass diminishes, the BMR further decreases.

This cycle of reduced muscle mass and a slower metabolism makes weight loss more challenging and weight gain more likely.

Lifestyle factors exacerbating weight gain

Beyond the direct hormonal and metabolic impacts, lifestyle factors can significantly exacerbate weight gain during menopause.

Changes in sleep patterns, including insomnia and night sweats, are common menopausal symptoms that disrupt energy levels and can lead to increased cravings for calorie-dense foods. [5]

Stress, which can be amplified during this life stage due to various factors, can also lead to increased cortisol levels, promoting abdominal fat storage.

Feeling less motivation towards physical activity due to fatigue or joint discomfort can also reduce calorie expenditure, and combined with the underlying physiological shifts, can lead to weight gain.

Does HRT cause weight gain?

No, HRT doesn't directly cause significant weight gain, [6] but weight gain is common in middle age regardless of HRT.

Many women experience weight changes during menopause due to natural hormonal shifts, metabolism slowing down, and sometimes temporary fluid retention from certain HRT types.

On balance, HRT may indirectly help to improve your overall wellbeing. [7] This means you can manage your weight better, because you may be more likely to exercise, eat a more balanced diet and have higher energy levels. But, it’s important to note that HRT doesn't work the same way for everyone. Its beneficial effects largely depend on personal factors such as your menopause symptoms, lifestyle, and medical history.

The broader benefits of HRT

While easing hot flushes is a primary driver for many women seeking HRT, its benefits are far more extensive.

HRT can positively impact bone health, significantly reducing the risk of osteoporosis and fractures. [8] It may also improve mood, cognitive function, and sleep quality, although evidence remains mixed. [9]

HRT has been linked to improvements in cardiovascular health when initiated early in the menopausal transition. [10] Emerging evidence also suggests HRT may help improve metabolic health, including belly fat, blood pressure and insulin resistance. [11]

HRT may improve insulin sensitivity, which helps prevent weight gain and lowers the risk of type 2 diabetes. It may also help the body respond better to strength training, which can preserve (or build) muscle mass, a key component for keeping metabolism healthy and supporting sustainable weight management.

Combining HRT and GLP-1s

While both HRT and GLP-1 medications, such as Mounjaro and Wegovy, can help with weight management and metabolic health individually, using them together may have an added benefit.

The reason behind combining HRT and GLP-1s is down to how they work: in different, but complementary ways. HRT addresses the hormonal changes that can change fat distribution and slow metabolism during menopause. At the same time, GLP-1s directly target appetite regulation and blood sugar control, promoting weight loss and improving insulin sensitivity. [12]

Early research suggests that this combined approach can amplify weight loss and improve body composition beyond what either treatment can achieve alone. A notable study highlighted that women who combined the GLP-1 medication with HRT lost an average of 17%of their body weight, compared to 14% for women on tirzepatide (Mounjaro) alone in an 18-month trial. [13]

Beyond visible weight loss, the combination of HRT and GLP-1s when guided by your clinician, could offer a pathway to more holistic metabolic health improvements.

Eligibility for HRT, GLP-1s, or both

Eligibility for HRT depends on factors such as the presence of menopausal symptoms, personal and family medical history (including risks for cardiovascular disease, certain cancers, and blood clots), and individual preferences. On the other hand, candidacy for GLP-1 medications is determined by body mass index (BMI).

Integrating lifestyle changes for sustainable results

Sustainable lifestyle changes are still important, whatever treatment choices you make on your menopause journey. A balanced diet rich in whole foods, lean protein, and fibre, coupled with regular physical activity, including strength training to preserve muscle mass, is crucial.

The landscape of women's health and weight management is continually evolving. The growing understanding of how hormonal changes impact metabolism and body composition during menopause is leading to more targeted and effective treatments.

Hormone Replacement Therapy (HRT) offers a means to rebalance hormones, potentially improving metabolic function and fat distribution, while GLP-1 medications have emerged as highly effective agents for weight loss and blood sugar control.

Consulting with a healthcare professional is key to determine your eligibility and develop an integrated plan that includes sustainable healthy lifestyle strategies. This multifaceted approach offers women the support they need to reclaim control over their health and wellbeing during and beyond menopause, paving the way for a healthier, more confident future.

Find out what treatment is suitable for you on MedExpress.

References

1. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021 Jan 1;106(1):1-15. doi: 10.1210/clinem/dgaa764.
2. Kersten Bartelt, RN, Caleb Cox. Hormone Replacement Therapy Prescriptions for Women Up 72% Since 2021 [Internet]. Cosmos Study. 2025. Available from:https://www.epicresearch.org/articles/hormone-replacement-therapy-prescriptions-for-women-up-72-since-2021
3. Connnor Campbell. Menopause Statistics Report 2025. Chemist 4 u. [Internet]. 2026. Available from: https://www.chemist-4-u.com/guides/female-health/menopause-statistics/
4. Duval K, Prud'homme D, Rabasa-Lhoret R, Strychar I, Brochu M, Lavoie JM, Doucet E. Effects of the menopausal transition on energy expenditure: a MONET Group Study. Eur J Clin Nutr. 2013 Apr;67(4):407-11. doi: 10.1038/ejcn.2013.33. Epub 2013 Feb 20. Erratum in: Eur J Clin Nutr. 2014 Jan;68(1):142.
5. Bermingham KM, Linenberg I, Hall WL, Kadé K, Franks PW, Davies R, Wolf J, Hadjigeorgiou G, Asnicar F, Segata N, Manson JE, Newson LR, Delahanty LM, Ordovas JM, Chan AT, Spector TD, Valdes AM, Berry SE. Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study. EBioMedicine. 2022 Nov;85:104303. doi: 10.1016/j.ebiom.2022.104303. Epub 2022 Oct 18.
6. Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews 2000, Issue 1. Art. No.: CD001018. DOI: 10.1002/14651858.CD001018.
7. Fischer B, Gleason C, Asthana S. Effects of hormone therapy on cognition and mood. Fertil Steril. 2014 Apr;101(4):898-904. doi: 10.1016/j.fertnstert.2014.02.025.
8. Gambacciani M, Levancini M. Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny. 2014 Sep;13(4):213-20. doi: 10.5114/pm.2014.44996. Epub 2014 Sep 9.
9. Fischer B, Gleason C, Asthana S. Effects of hormone therapy on cognition and mood. Fertil Steril. 2014 Apr;101(4):898-904. doi: 10.1016/j.fertnstert.2014.02.025.
10. Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022 May-Jun 01;28(3):208-223. doi: 10.1097/PPO.0000000000000591.
11. Salpeter SR, Walsh JM, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab. 2006 Sep;8(5):538-54. doi: 10.1111/j.1463-1326.2005.00545.x.
12. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
13. Science Daily. Hormone therapy supercharges tirzepatide, unleashing major weight loss after menopause. The Endocrine Society. [Internet] 2025. Available from: https://www.sciencedaily.com/releases/2025/07/250713031441.htm